Automatic substitute computed tomography generation and contouring for magnetic resonance imaging (MRI)-alone external beam radiation therapy from standard MRI sequences by Dowling, Jason A. et al.
Accepted Manuscript
Automatic substitute CT generation and contouring for MRI-alone external beam
radiation therapy from standard MRI sequences
Jason A. Dowling, Ph.D, Jidi Sun, M.Sc, Peter Pichler, M.P.H, David Rivest-Hénault,
Ph.D, Soumya Ghose, Ph.D, Haylea Richardson, B.Med.Rad.Sc, Chris Wratten,
FRANZCR, Jarad Martin, M.D, Jameen Arm, M.Sc, Leah Best, B.Sc, Shekhar S.
Chandra, Ph.D, Jurgen Fripp, Ph.D, Frederick W. Menk, Ph.D, Peter B. Greer, Ph.D
PII: S0360-3016(15)03247-2
DOI: 10.1016/j.ijrobp.2015.08.045
Reference: ROB 23147
To appear in: International Journal of Radiation Oncology • Biology • Physics
Received Date: 19 May 2015
Revised Date: 5 August 2015
Accepted Date: 25 August 2015
Please cite this article as: Dowling JA, Sun J, Pichler P, Rivest-Hénault D, Ghose S, Richardson H,
Wratten C, Martin J, Arm J, Best L, Chandra SS, Fripp J, Menk FW, Greer PB, Automatic substitute
CT generation and contouring for MRI-alone external beam radiation therapy from standard MRI
sequences, International Journal of Radiation Oncology • Biology • Physics (2015), doi: 10.1016/
j.ijrobp.2015.08.045.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Dowling et al.  1 
 
 
Automatic substitute CT generation and contouring for MRI-alone external beam radiation 
therapy from standard MRI sequences 
 
Jason A. Dowling, Ph.D.1,3*, Jidi Sun, M.Sc.3, Peter Pichler M.P.H.2, David Rivest-Hénault Ph.D.1, 
Soumya Ghose Ph.D.1, Haylea Richardson B.Med.Rad.Sc.2, Chris Wratten, FRANZCR2,3 , Jarad 
Martin M.D. 2,3, Jameen Arm M.Sc.2, Leah Best B.Sc.4, Shekhar S. Chandra Ph.D.5, Jurgen Fripp 
Ph.D.1, Frederick W Menk Ph.D.3 Peter B. Greer Ph.D.2,3 
 
 
1 CSIRO Australian e-Health Research Centre, Queensland, Australia  
2 Calvary Mater Newcastle Hospital, New South Wales, Australia 
3
 University of Newcastle, New South Wales, Australia  
4 Department of Radiology, Hunter New England Health, New South Wales, Australia  
5 School of Info. Tech. and Electrical Engineering, University of Queensland, Australia 
 
 
Corresponding author:  
Jason A. Dowling 
CSIRO Australian e-Health Research Centre  
                                                                 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Dowling et al.  2 
 
 2 
Level 5 UQ Health Science Building 901/16, Royal Brisbane and Women's Hospital,  
Herston, QLD, 4029, Australia 
Phone: +61 73253 3634, Fax: +617 3253 3690 
Email: jason.dowling@csiro.au  
 
Shortened Running Title:  
Substitute CT for MRI-alone treatment planning 
 
 
 
Acknowledgments:  
This work was supported by Cancer Council New South Wales research grant RG11-05, the 
Prostate Cancer Foundation of Australia (Movember Young Investigator Grant YI2011) and Cure 
Cancer Australia. 
 
 
Conflicts of Interest:  
None. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 
Summary 
Retrospective validation of MR-alone treatment planning with 39 patients is evaluated.  Substitute 
CT (sCT) and contours were automatically generated for all patients.   The suitability of the method 
for clinical practice was demonstrated by a mean error between the sCT and real CT data (within 
body contour) of 0.6±14.7 HU.  The difference in point dose monitor units was mean 0.3±0.8%, 
with a 3D Gamma pass rate of 1.00±0.00 (2 mm/2%).   
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Abstract 
Purpose: Validation of automatic substitute CT (sCT) scans generated from standard T2 
weighted MR pelvic scans for MR-Sim prostate treatment planning.  
Methods and Materials:  A Siemens Skyra 3T MRI scanner with laser bridge, flat couch 
and pelvic coil mounts was used to scan 39 patients scheduled for external beam radiation 
therapy for localized prostate cancer. For sCT generation a whole pelvis MRI (1.6 mm 3D 
isotropic T2w SPACE sequence was acquired.  Three additional small field of view scans 
were acquired: T2w, T2*w and T1w flip angle 80⁰ for gold fiducials. Patients received a 
routine planning CT scan. Manual contouring of the prostate, rectum, bladder and bones 
was performed independently on the CT and MR scans. Three experienced observers 
contoured each organ on MRI allowing inter-observer quantification. 
To generate a training database, each patient CT scan was co-registered to their whole 
pelvis T2w using symmetric rigid registration and structure guided deformable registration.  
A new multi-atlas local weighted voting method was used to generate automatic contours 
and sCT results.   
Results: The mean error in Hounsfield units (HU) between the sCT and corresponding 
patient CT (within the body contour) was 0.6±14.7 (mean±1 SD) with a mean absolute 
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error of 40.5±8.2 HU.   Automatic contouring results were very close to the expert inter-
observer level (DSC):  prostate 0.80±0.08, bladder 0.86±0.12, rectum 0.84±0.06, bones: 
0.91±0.03 and body:1.00±0.003.  The change in monitor units (MU) between the sCT-
based plans relative to the gold standard CT plan for the same dose prescription was found 
to be 0.3±0.8%.   The 3D Gamma pass rate was 1.00±0.00 (2 mm/2%).   
Conclusions: The MR-Sim setup and automatic sCT generation methods using standard 
MR sequences generates realistic contours and electron densities for prostate cancer 
radiation therapy dose planning and DRR generation.    
 
 
Key Words: Radiation therapy planning; prostate cancer; electron density; MRI, pseudo CT; 
substitute CT, synthetic CT 
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1 Introduction 
Computed tomography (CT) scans are currently critical for image guided radiation therapy dose 
planning.  CT allows a calibration relationship between voxel values and tissue electron density to 
be established for dose calculations, and the generation of digitally reconstructed radiographs 
(DRRs)1.  However Magnetic Resonance Imaging (MRI) offers much improved soft tissue 
visualisation, does not expose a patient to ionizing radiation, and offers a number of functional 
imaging options2.  Advantages of planning directly on MRI scans include reductions in costs and 
uncertainties introduced by the registration process3.  Further motivation for MRI based substitute 
CT (sCT) scans (also known as synthetic or pseudo CT) are hybrid MRI-linear accelerator devices 
and MRI-PET attenuation correction2,4–7.   A significant barrier to MRI-alone workflows however is 
that scans cannot be calibrated to electron density due to different imaging principals and therefore 
dose calculations cannot currently be performed.   
Methods to estimate electron density information from MRI for both radiation therapy and 
attenuation correction need to consider geometric distortion, magnetic field inhomogeneities, 
gradient nonlinearity and patient-induced susceptibility8.   Four main approaches have been 
developed: 
1. Bulk density assignment involves setting a region within the MRI to a homogenous density 
(for example, water and bone)5,9–14.  The region contouring is usually performed manually 
which is time consuming (especially for bone). The main advantage of the approach is 
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simplicity, however calculations may not be as accurate as CT and realistic DRRs are not 
able to be constructed. 
2. Registration and atlas based approaches involve the rigid and deformable mapping of CT 
intensities onto a target MRI scan.   One approach is to register a single CT to a target MRI 
15
 resulting in an sCT, however a single registration is unlikely to accurately map complex 
anatomy.  More accurate approaches involving a training set of registered CT-MRI image 
pairs which are then combined into an average CT-MRI atlas which can be mapped to a new 
MRI scan16,17.  Pairwise registration of each atlas MRI to a target MRI followed by  fusion 
of the co-registered CT images to estimate HU generally improves accuracy18,19.  
Advantages of this approach involve the use of a priori geometric information and 
registration regularization to maintain realistic anatomical deformation. Atlas based 
approaches are currently the only fully automated methods for converting a single, standard 
MRI sequence to sCT and are more robust to intensity differences between images. The 
main disadvantage of are that the registration algorithms used may be unable to deform atlas 
images to match anatomical properties which are missing from an atlas-training set. 
Multiple pairwise registration can also be CPU-intensive, however the overall plausibility of 
the result is implicitly guaranteed. 
3. Regression, classification, or direct approaches aim to characterize tissue properties directly 
from MR image intensities.    As with atlas-based approaches, most regression methods rely 
on a training set of co-registered CT-MR scans to learn the intensity mapping20.   Generally 
a minimum of three tissue classes (soft tissue, air and bone) are classified from one or more 
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MR images of the same patient anatomy21,22.  Classes for water and fat may be added for 
increased accuracy22–27 .  A disadvantage of these approaches is the reliance on a 
combination of MRI sequences for tissue class differentiation and on research-only 
sequences such as ultra-short echo time (UTE).  These sequences can significantly add to 
acquisition time and increase patient discomfort and motion.  Advantages of these methods 
include execution speed and a potential increase in accuracy over atlases (reduction in 
registration error and greater robustness to abnormal anatomy), however it is difficult to 
guarantee the overall anatomical plausibility of the result.  
4. Hybrid approaches have been proposed which combine both atlas and regression methods 
and show promise in sCT generation from a single, standard MRI sequence20,28 .   
This paper presents a retrospective study involving an MRI-simulator (with a flat couch top and coil 
mount to reduce body deformation).  Results from a novel multi-atlas method using advanced 
registration techniques and local weighted voting to automatically map electron densities to 
standard MRI scans are presented.  Multiple contoured patient MRI-CT sets are mapped to a patient 
and combined to create an accurate sCT with automatic structures. This sCT is then used for dose 
planning and DRR generation. Validation is performed by comparing doses calculated on the sCT 
with those on the planning CT.  This approach should facilitate the introduction of MRI-alone 
prostate planning to routine clinical use as well as future MRI-based adaptive treatments. 
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2. Patients and Method  
2.1 Patient Data Collection 
Ethics approval for the study protocol was obtained from the local area health ethics committee and 
informed consent obtained from all patients. Patients were aged between 58-78 years, and all were 
diagnosed with tumours staged between T1-T3 (T1cN0M0 most common). BMIs ranged from 19.1-
35.4.  Each patient had three prostate pure gold fiducial markers of diameter 1.0x3.0 mm inserted 
trans-rectally by a urologist 1-2 weeks prior to the planning image acquisition.   42 patients in total 
were recruited, however the first three patient scans were acquired soon after commissioning the 
MRI scanner, and these scans were excluded due to an inadequate field of view for treatment 
planning and significant artefacts.   
CT scans were acquired on a GE LightSpeedRT large bore scanner (2.5 mm slices) or a Toshiba 
Acquilion (2.0 mm slices). Patients were scanned with a full bladder and empty rectum.  All 
patients followed a bowel preparation protocol (high fibre diet and daily Metamucil intake). Patients 
were positioned supine on a rigid couch-top with knee and ankle immobilisation stocks.  
Four MRI sequences for each of the 39 patients were acquired with a Siemens Skyra 3T scanner.  
The scanner was equipped for MR simulation with a dedicated radiation therapy flat couch and coil 
mounts supplied by CIVCO (CIVCO Medical Solutions, Coralville, IA) and a laser bridge from 
LAP Lasers (LAP Laser, Luneburg, Germany). All patients were positioned by two radiation 
therapists.  Only conventional MR scanning sequences were used. The planning MR was a 3D, T2 
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weighted 1.6 mm isotropic SPACE (Sampling Perfection with Application optimized Contrasts 
using different flip angle Evolution) sequence with field-of-view to cover the entire pelvis 
(including all of the bladder). The prostate delineation sequence was a 2D axial T2 weighted 
sequence with field-of-view approximately 200x200 mm2. A further T1 weighted gradient echo 
sequence with flip angle 80 degrees was used to image intraprostatic gold seeds. A T2* scan was 
also acquired for the seeds (for a separate study validating the T1 weighted sequence).  Patients 
were MR imaged prior to treatment as close as possible to the acquisition of the conventional 
planning CT scan.  The parameters for each of these scans are summarised in Table 1.  
Patient images were uploaded into the Eclipse treatment planning software (Varian Medical 
Systems, Palo Alto, CA, USA, version 11.0). Gold seed positions were localised on the T1 scan and 
transferred to the aligned T2 MRI image set as a structure contour. In standard CT based planning 
this image was then manually registered to the CT image set by alignment of the gold seed contours 
to visible gold seeds on the CT image set. Only translations in the x, y and z planes were applied.  
To assess inter-observer contouring variability, the prostate (from the small field of view T2 scan), 
bladder and rectum (both from the whole pelvis T2 scan) for all patients were contoured 
independently by the same three observers (two experienced radiation oncologists and an 
experienced research radiation therapist).  As in previous papers29,30 we generated a gold standard 
contour for each organ using majority voting to combine the observer contours.  The use of 
STAPLE31 to combine these contours has previously been investigated (having no significant 
difference with voting30 ) and was not applied. The automatic segmentation tools from Varian 
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Eclipse were used for CT bone delineation and this contour was rigidly aligned to the whole pelvis 
MRI scan manually and adjusted by the research radiation therapist.  
Seven field intensity modulated treatment delivery is used at our centre for prostate treatments. The 
treatments were delivered in 37-39 fractions of 2 Gy per fraction. The Clinical Target Volume 
(CTV, prostate) to Planning Target Volume (PTV) margin used was 7 mm. 
2.2 Training data 
All image analysis was performed in 3D.  Before use the T2 scans were preprocessed with the 
following steps built using the Insight Segmentation and Registration Toolkit (ITK 4.4)32:  
1. N4 Bias field correction33 (B-spline fitting: [160, 3, 0, 0, 5], convergence: [100x100x100, 0, 
0.001], shrink factor: 3). 
2. Histogram equalization (levels: 1024, match points: 7, threshold at mean intensity). 
3. Smoothing via gradient anisotropic diffusion (10 iterations, time step: 0.03; conductance: 
1.0). 
To generate a training database, each patient CT scan was co-registered to their whole pelvis T2 
with a robust symmetric rigid registration34,35 followed by structure guided deformable registration 
(to promote bone rigidity while allowing high quality bladder and rectum registration36).    
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2.3 Conversion of a new patient MRI  
A multi-atlas local weighted voting method, based on a method applied by Artaechevarria et al.37 to 
brain scans was used to generate sCT and automatic contouring results for each target MRI scan.  
This method involves five main steps:  
1. All whole pelvis MRI scans (n=38, as leave-one-out) in the training database were registered 
to the target MRI using symmetric rigid34  followed by diffeomorphic demons registration 
38
.  Note that structure guided registration is not used here as structures are not available on 
the target MRI.  The rigid transform and deformation field from each of the 38 pairwise 
registrations were then also applied to binary images representing structures generated from 
contours from each training MRI.   
2. A patch around each voxel (radius=2 voxels) in the target MRI was compared with patches 
in the same location on the registered MRI images and a similarity metric computed (sum of 
squared differences).  The weights for each voxel on all registered MR images were then 
normalized to one. 
3. The normalized similarity for each voxel was then used as a weighting to generate the 
estimated HU from the same voxels in the co-registered CT’s.  Each voxel in the sCT image 
is therefore generated from the same voxel in each registered CT-MR image which has been 
weighted to match the MRI neighbourhood.   
4. The same weights were similarly used to determine the spatial locations for each binary 
image (representing structures).     
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5. Standard MRI sequences have reduced capacity to extract signal from tissues with shorter 
echo times.  A small systematic difference in the body contour on MRI and CT for each 
patient was observed representing missing signal from collagen.  A 1mm expansion was 
added to the sCT to account for this missing outer skin layer.  The dilated skin was assigned 
a value of 47 HU based on sampling of this area on the planning CT.  The automatic body 
contour was expanded in the same way.  
6. The generated sCT and structures (converted from binary images) were output to a DICOM-
RT directory39.  
2.4 Validation  
A leave-one-out approach was used. In this testing methodology, to avoid biasing results, each sCT 
is generated without data from the patient being tested.  Therefore 38 patient scans were used to 
generate each sCT, and to evaluate organ segmentation accuracy. 
The quality of the sCT conversion was assessed in three ways: direct comparison of voxel intensity 
differences between the sCT and the CT (mean and mean absolute errors); differences in dose 
distributions; and automatic contour accuracy. 
To evaluate dose differences, the sCT images were imported into the corresponding patient record 
in the treatment planning system. The existing CT based treatment plans including the CT defined 
structures for each patient were then copied and attached to the sCT images (using bone for initial 
alignment, then further refinement based on the fiducial markers according to the clinical protocol). 
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To evaluate dose differences, the dose at the ICRU point, 3D gamma evaluation, and dose-volume 
histogram (DVH) parameters for the planning target volume (PTV) were compared.  
The automatic contours were compared against the manual contours using the Dice Similarity 
Coefficient (DSC = 2 ( A ⋂ B / (A ⋃ B) ) and the mean absolute surface distance (MASD) which is 
calculates the average absolute Euclidean distance between surfaces (ITK, 
ContourMeanDistanceImageFilter class).  
3. Results  
The mean error in HU between the sCT and matching patient CT data (within the patient’s body 
contour) was 0.6±14.7 (mean±1 SD). The mean absolute error within the same contour was 
40.5±8.2 HU.   Figure 1 shows the automatically generated sCT, the original CT (registered to the 
patient’s MRI) and the difference between the estimated and actual CT volumes from one study 
patient (number 6).   
 
With a 2 Gy prescribed dose at the ICRU point, the change in monitor units (MU) was used to 
compare the dose change for the plans using sCT images relative to the gold standard CT plan. A 
reference ICRU dose point was created on the CT dose distribution and then the same point was 
transferred to the sCT. The percentage difference of the dose calculated at the reference point 
between the two plans was -0.3±0.8%, range [-1.5, 1.8].  
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3D gamma analysis was also used to evaluate dose.  This evaluation method includes both dose-
difference (DD) and distance-to-agreement (DTA) criteria40. In this study 3D gamma analysis was 
performed with global dose criteria of 2mm/2% (DTA/DD) and 1mm/1%. The dose distribution 
calculated on the CT plan was considered the reference, while the sCT plan dose distribution was 
considered the evaluated quantity. The dose matrices were exported from Varian Eclipse.  The two 
dose images were aligned (Matlab, MathWork) based on the isocentre location in each image, as the 
CT and MR images were already registered in Eclipse. The sCT plan dose matrix was then 
interpolated to the reference CT plan dose matrix. Finally, the 3D gamma analysis was performed 
using inhouse Matlab code (Figure 2). Three different dose thresholding approaches were used, a 
90% threshold capturing dose within the PTV region (P), a global 10% threshold capturing dose 
within the entire body contour (B), and a morphological erosion operation was applied to exclude 
the body surface (~15mm) where gamma failures occur due to small differences in the body contour 
of CT and sCT (B’).  
 
The dose distributions on CT and sCT were also compared using DVH parameters (D90%, D50% 
and D5%). The mean ± std (25%, 75% quartiles) of the CT and sCT DVH parameter differences 
(sCT-CT) were calculated as ∆D95% = -0.3±1.1 (-0.9, 0.2); ∆D50%=-0.5±1.1 (-1.4, -0.0); ∆D5% = 
-0.4±1.2 (-1.3, 0.0).  No significant differences were found (t-test, α=0.05) for D95% (p=0.1792), 
D50% (p=0.0503) and D5% (p=0.1646).  Dosimetric results (dose comparison, gamma, and DVH) 
for the best and worst patient gamma scores are visually shown in Figures 3 and 4.  
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The automatic bone contours on the MR scans were very accurate with a DSC of 0.91±0.03 and 
MASD of 1.45±0.47 mm.  Mean automatic organ contouring results compared to manual contours 
were all above 0.8 DSC and were close to the inter-observer level (Table 2).    
4. Discussion  
The results presented in this paper compare favourably with previous literature on sCT generation 
for MR-alone prostate radiation therapy planning. Chen et al.41 applied a bulk density approach and 
found dose difference between sCT and planning CT of 2.5%.  Using an automatic average atlas 
approach Anonymous et. al16 reported a point dose difference between sCT and planning CT of 
1.3%.  Korhonen et al.42 used manual bone contouring, and a regression approach and achieved an 
absolute difference of 11±9 HU and for soft tissue and 99±100 HU for bony tissue for 10 patients. 
They reported high gamma agreement using a single axial plane 2D evaluation for 7 field IMRT 
treatments with 2%,2mm criteria of 99.6±0.3%. DVH parameter agreements (D95%, D50% and 
D5%) were 0.3±0.2%. For these comparisons the CT and sCT body contours were adjusted to be 
equivalent. Kim et al.18 reported for a semi-automatic (bone needed to be manually contoured) 
method a MAE of 74 HU and mean dose difference of 0.75%.  In this paper we have described a 
fully automatic method to achieve an MAE of 40±8.2 HU with a mean dose difference of 0.3±0.8% 
for a large patient dataset.  Gamma analysis and DVH parameter comparisons demonstrates that the 
dose distribution for all patients were in a high level of agreement. In this work there was no 
normalization of the body contour between CT and sCT therefore the most Gamma failures 
occurred at the body surface region where there were differences in contour, (dose was present in 
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one scan but not the other). Gamma calculations were therefore also performed excluding this 
region. There is currently no consensus on how to evaluate sCT dose distributions compared to CT 
so we have used the most commonly reported evaluation metrics (MAE HU, point dose, Gamma 
and DVH parameters).   
Our method has been developed with a standard clinical workflow in mind and does not rely on 
specialised sequences, or manual bone contouring.   The automatic MRI bone contours were found 
to have a high level of accuracy which will be important in the clinical workflow to assess doses to 
these structures.    
Previous work from our group has reported that geometric distortion within our MR-Sim setup was 
found to be accurate, with organ dimensions, dose distributions and DRR based setup within 
acceptable limits compared to CT 43.  The MRI coil mount reduces body deformation but has an 
impact on image quality (the coil needs to be positioned with a minimal and uniform body-to-coil 
distance in order to maximize image quality)44. 
Requirements for accurate sCT conversion include carefully matching the patient position between 
CT and MR for training data, MR scans with an adequate field of view to match a standard planning 
CT and high quality sequence acquisition (preferably isotropic voxels).  Accurate co-registration of 
CT-MR scans (preferably using structure guided registration) is a critical step in developing training 
data for sCT generation.   
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5. Conclusions  
This study has shown that substitute CT scans can be automatically generated from MR scans using 
conventional T2 weighted sequences and that dose calculations are comparable to conventional CT 
scan dose calculations. The MR-only workflow is efficient and only requires one imaging session 
for the patient. 
A major advantage of the technique is that it does not require specialized or research sequences 
(such as UTE), and only a single sequence is required for substitute CT generation, decreasing 
scanning time and potential patient motion. 
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Figures 
 
Figure 1: Column A: Original MRI from study participant six.  B: generated sCT, C: original 
patient CT.  D shows the MAE between B and C.   
Figure 2: Gamma evaluation results comparing the original CT plan to the same plan recalculated 
on the sCT scan.  P=Prostate, B=Body, B’=Body with skin surface removed.  
Figure 3: Results for patient 10 (best gamma result).  A: original patient CT scan with dose plan 
overlaid.   B: Estimated sCT for this patient (PTV contoured in blue).  The gamma map (2mm/2%, 
body) is shown in C.  D shows the DVH results (the dashed line with stars is from the sCT and the 
solid line with circles is the actual CT).   
Figure 4: Results for study patient 36 (worst gamma result). Same layout as Figure 3.  Note the 
significant difference in rectal air and prostate position.  
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Table 1. MRI Acquisition parameters*.  
 T2 SFOV T2 LFOV T2* T1 
Scan Type 2D Axial TSE 3D SPACE TSE GRE GRE 
TE (ms) 97 102 12 6.6 
TR (ms) 1400 1200 689 689 
Flip Angle (°) 135 135 25 80 
FOV (mm) 200 430 200 200 
Slice Thickness (mm) 2 1.56 2 2 
Abbreviations:  SFOV=small field of view; LFOV=large field of view; TSE=turbo spin echo; 
GRE=gradient echo; TE=echo time; TR=repetition time. 
*Scans were created with a Siemens Skyra 3.0 Tesla magnet. 
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Table 2. Dice Similarity Coefficient (DSC) and Mean Absolute Surface Distance (MASD) results 
for automatic organ contouring compared to gold standard (fused) expert manual contours.  The 
middle column shows the inter-observer overlap between the three experts for each organ.  The 
final column shows the mean error (ME) and mean absolute error (MAE) of HU estimates within 
each automatic contour.  
 
 
 Automatic vs manual 
contour 
Inter-observer (n=3) 
overlap 
Difference between sCT and 
CT within automatic contour 
 DSC MASD 
(mm) 
DSC MASD 
(mm) 
ME (HU) MAE (HU) 
Body 1.00±0.00 0.55±0.56 N/A N/A -0.56±14.17 40.45±8.16 
Bones 0.91±0.03 1.45±0.47 N/A N/A -6.43±46.47 134.24±24.04 
Bladder 0.86±0.12 5.10±4.57 0.95 ± 0.01 0.91±0.29 -2.9±18.71 24.05±13.62 
Rectum 0.84±0.06 2.37±1.34 0.82 ± 0.07 2.64±1.55 6.86±81.72 88.07±60.81 
GTV 0.80±0.08 2.30±1.01 0.84 ± 0.11 1.98±1.59 -0.47±11.82 16.47±4.50 
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